Статья

The initial impact of the SARS-CoV-2 pandemic on epilepsy research

N. Volkers, S. Wiebe, A. Asadi-Pooya, G. Balagura, P. Gómez-Iglesias, A. Guekht, J. Hall, A. Ikeda, N. Jetté, N. Kishk, P. Murphy, E. Perucca, J. Pérez-Poveda, E. Sanya, E. Trinka, D. Zhou, J. Cross,
2021

The COVID-19 pandemic has changed the face of many practices throughout the world. Through necessity to minimize spread and provide clinical care to those with severe disease, focus has been on limiting face-to-face contact. Research in many areas has been put on hold. We sought to determine the impact of the COVID-19 pandemic on epilepsy research from international basic science and clinical researchers. Responses to five questions were solicited through a convenience sample by direct email and through postings on the ILAE social media accounts and an ILAE online platform (utilizing Slack). Information was collected from 15 respondents in 11 countries by email or via Zoom interviews between May 19, 2020, and June 4, 2020. Several themes emerged including a move to virtual working, project delays with laboratory work halted and clinical work reduced, funding concerns, a worry about false data with regard to COVID research and concern about research time lost. However, a number of positive outcomes were highlighted, not least the efficiency of online working and other adaptations that could be sustained in the future. © 2021 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • N. Volkers
    International League Against Epilepsy, Flower Mound, TX, United States
  • S. Wiebe
    Departments of Clinical Neurosciences and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
  • A. Asadi-Pooya
    Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • G. Balagura
    Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, PA, United States
  • P. Gómez-Iglesias
    Pediatric Neurology and Muscular Diseases Unit, IRCCS "G. Gaslini" Institute, Genova, Italy
  • A. Guekht
    Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy
  • J. Hall
    Epilepsy Unit, Department of Neurology, Hospital Clínico San Carlos, Health Research Institute “San Carlos” (IdISCC), Universidad Complutense de Madrid, Madrid, Spain
  • A. Ikeda
    Moscow Research and Clinical Center for Neuropsychiatry, Moscow, Russian Federation
  • N. Jetté
    Department of Neurology, Neurosurgery and Medical Genetics, Russian National Research Medical University, Moscow, Russian Federation
  • N. Kishk
    Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • P. Murphy
    Division of Health Outcomes and Knowledge Translation Research, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
  • E. Perucca
    Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
  • J. Pérez-Poveda
    Epilepsy Ireland, Dublin, Ireland
  • E. Sanya
    Division of Clinical and Experimental Pharmacology, Department of Internal Medicine and Therapeutics, University of Pavia, Pavia and IRCCS Mondino Foundation, Pavia, Italy
  • E. Trinka
    ERN EpiCARE, United Kingdom
  • D. Zhou
    Neuroscience Department, Faculty of Medicine, Xavierian University, and Hospital Universitario San Ignacio, Bogotá, Colombia
  • J. Cross
    Neurology Division, Medicine Department, University of Ilorin Teaching Hospital, Ilorin, Nigeria
Название журнала
  • Epilepsia Open
Страницы
  • -
Издатель
  • Blackwell Publishing Ltd
Тип документа
  • Review
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus